Clinical Trial Update: Anti-VEGF Therapy Versus Dexamethasone Implant for DME [Phase 4]

View source ↗

Summary

Phase 4 trial comparing anti-VEGF therapy to dexamethasone implant for clinically significant macular edema due to diabetes mellitus; status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Clinically Significant Macular Edema Due to Diabetes Mellitus

Drugs mentioned

• anti-VEGF therapy
• dexamethasone implant

Snippet

Sponsor: Sudhalkar Eye Hospital | Conditions: Clinically Significant Macular Edema Due to Diabetes Mellitus | Phase 4 | Status: UNKNOWN